…
CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing; preferred provider management and reimbursement; retrospective utilization, facility claim, and professional review; pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management customers, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
CorVel provides technology-enabled workers' compensation, medical bill review, pharmacy benefits and claims-management services to insurers, employers and third-party administrators. Long-term growth may be supported by outsourcing of claims administration, demand for healthcare cost containment and adoption of its data-driven platform, making it potentially attractive for its recurring-fee model and consistent profitability.
Principal risks include regulatory changes in healthcare and workers' compensation, competition from larger insurers and tech entrants, and revenue sensitivity to claim volumes and economic cycles that investors should monitor.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
| Income before tax | 143.13M | 120.82M | 95.10M | 84.55M | 84.51M |
| Net income | 110.34M | 95.17M | 76.25M | 66.36M | 66.41M |
| Selling general administrative | 89732.00M | 88.90M | 76.59M | 73.70M | 67.60M |
| Selling and marketing expenses | - | - | 26.25M | - | - |
| Gross profit | 232.86M | 209.73M | 171.69M | 158.26M | 152.11M |
| Reconciled depreciation | 31.76M | 29.54M | 26.25M | 25.12M | 23.92M |
| Ebit | 143.13M | 120.82M | 95.10M | 59.43M | 60.60M |
| Ebitda | 174.90M | 150.36M | 121.35M | 84.55M | 84.51M |
| Depreciation and amortization | 31.76M | 29.54M | 26.25M | 25.12M | 23.92M |
| Operating income | 143.13M | 120.82M | 95.10M | 59.43M | 60.60M |
| Other operating expenses | 815.40M | 774.76M | 700.21M | 634.01M | 561.72M |
| Interest expense | - | - | - | -25.12M | -23.92M |
| Tax provision | 32.79M | 25.66M | 18.85M | 18.19M | 18.10M |
| Income tax expense | 32.79M | 25.66M | 18.85M | 18.19M | 18.10M |
| Total revenue | 958.53M | 895.59M | 795.31M | 718.56M | 646.23M |
| Total operating expenses | 89.73M | 88.90M | 76.59M | 73.70M | 67.60M |
| Cost of revenue | 725.66M | 685.86M | 623.62M | 560.30M | 494.12M |
| Total other income expense net | - | - | - | 25.12M | 23.92M |
| Net income from continuing ops | 110.34M | 95.17M | 76.25M | 66.36M | 66.41M |
| Net income applicable to common shares | - | - | - | 66.36M | 66.41M |
| Breakdown | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
| Total assets | 642.99M | 545.98M | 474.42M | 393.92M | 415.25M |
| Intangible assets | 0.26M | 0.44M | 37.99M | 1.24M | 1.67M |
| Other current assets | 127.91M | 111.98M | 99.56M | 91407.00M | 84.90M |
| Total liab | 248.75M | 223.99M | 226.77M | 191.75M | 202.85M |
| Total stockholder equity | 394.23M | 321.99M | 247.65M | 202.18M | 212.40M |
| Deferred long term liab | - | - | - | - | 1.69M |
| Other current liab | 48.38M | 46.84M | 129.26M | 35.68M | 48.01M |
| Common stock | 0.01M | 0.01M | 0.00M | 3.00M | 0.00M |
| Capital stock | 0.01M | 0.01M | 0.00M | 0.00M | 0.00M |
| Retained earnings | 1013.43M | 903.09M | 807.92M | 731.67M | 665.30M |
| Other liab | - | - | - | - | 1.69M |
| Good will | 36.81M | 36.81M | 36.81M | 39.66M | 38.96M |
| Other assets | - | - | 0.00M | - | 0.48M |
| Cash | 233.07M | 170.58M | 105.56M | 71.33M | 97.50M |
| Total current liabilities | 228.07M | 204.04M | 184.50M | 167.89M | 171.37M |
| Current deferred revenue | 147.94M | 132.28M | 29.96M | 107.00M | 95.58M |
| Net debt | -204.97M | -142.50M | -74.17M | -47.47M | -54.36M |
| Short term debt | 7.42M | 8.13M | 8.86M | 9.90M | 13.35M |
| Short long term debt total | 28.11M | 28.08M | 31.40M | 23.86M | 43.14M |
| Other stockholder equity | -619.20M | -581.10M | -560.28M | -532.49M | -452.91M |
| Property plant equipment | - | - | - | 82.77M | 76.27M |
| Total current assets | 462.30M | 386.69M | 302.23M | 243.77M | 264.99M |
| Net tangible assets | - | - | - | 164.12M | 173.91M |
| Net receivables | 101.31M | 104.13M | 97.11M | 81.03M | 82.59M |
| Inventory | - | - | - | -91315.59M | - |
| Accounts payable | 24.32M | 15.42M | 16.41M | 15.31M | 14.43M |
| Common stock total equity | - | - | - | 0.00M | 0.00M |
| Retained earnings total equity | - | - | - | 731.67M | 665.30M |
| Non currrent assets other | 0.62M | 0.45M | 41144.15M | -0.22M | 0.48M |
| Non current assets total | 180.69M | 159.29M | 172.19M | 150.15M | 150.25M |
| Capital lease obligations | 28.11M | 28.08M | 31.40M | 23.86M | 43.14M |
| Breakdown | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
| Investments | - | -35.76M | -29.24M | -26.32M | -29.82M |
| Change to liabilities | - | - | - | -8.76M | 9.47M |
| Total cashflows from investing activities | -45.36M | -35.76M | -29.24M | -26.32M | -29.82M |
| Total cash from financing activities | -47.80M | -26.54M | -35.76M | -82.14M | -79.61M |
| Change to operating activities | - | - | - | - | -14.29M |
| Net income | 110.34M | 95.17M | 76.25M | 66.36M | 66.41M |
| Change in cash | 62.49M | 65.02M | 34.23M | -26.18M | -42.21M |
| Begin period cash flow | 170.58M | 105.56M | 71.33M | 97.50M | 139.72M |
| End period cash flow | 233.07M | 170.58M | 105.56M | 71.33M | 97.50M |
| Total cash from operating activities | 155.64M | 127.31M | 99.24M | 82.29M | 67.22M |
| Depreciation | 31.76M | 29.54M | 26.25M | 25.12M | 23.92M |
| Change to account receivables | 2.70M | -10.46M | -17.90M | 0.34M | -18.02M |
| Sale purchase of stock | -56.21M | -37.60M | -45.71M | -93.67M | -90.08M |
| Other cashflows from financing activities | -47747.21M | 11.07M | 9.95M | 11.53M | 10.47M |
| Change to netincome | - | - | - | 5.28M | 7.78M |
| Capital expenditures | 45.36M | 35.76M | 29.24M | 26.32M | 29.82M |
| Change receivables | - | - | - | 0.34M | -18.02M |
| Cash flows other operating | - | - | - | -6.05M | -22.34M |
| Cash and cash equivalents changes | - | - | - | -26.18M | -42.21M |
| Change in working capital | 2.52M | -1.83M | -7.05M | -14.47M | -30.88M |
| Stock based compensation | 5.41M | 5.71M | 4.98M | 5.56M | 5.20M |
| Other non cash items | 0.82M | 3.89M | 2.12M | 1.63M | 0.28M |
| Free cash flow | 110.28M | 91.56M | 70.00M | 55.97M | 37.40M |
Sector: Financial Services Industry: Insurance Brokers
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CRVL CorVel Corp |
-0.33 0.40% |
82.83 | 31.99 | 23.75 | 3.68 | 8.92 | 3.48 | 18.57 |
| MRSH Marsh & McLennan Companies, Inc. |
1.50 0.73% |
206.32 | 22.03 | 15.87 | 3.07 | 5.67 | 3.82 | 14.80 |
| AON Aon PLC |
3.36 1.00% |
338.17 | 19.50 | 17.61 | 4.19 | 7.68 | 4.95 | 13.01 |
| AJG Arthur J Gallagher & Co |
-0.52 0.18% |
281.10 | 41.13 | 17.09 | 4.21 | 2.74 | 4.93 | 19.58 |
| WTW Willis Towers Watson PLC |
0.52 0.16% |
329.38 | 19.92 | 14.56 | 2.96 | 3.91 | 3.52 | 13.08 |
CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing; preferred provider management and reimbursement; retrospective utilization, facility claim, and professional review; pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management customers, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.
5128 Apache Plume Road, Fort Worth, TX, United States, 76109
817 390 1416
5239
| Name | Title | Year Born |
|---|---|---|
| Mr. Michael G. Combs | Pres & CEO | 1964 |
| Mr. Brandon T. O'Brien | Chief Financial Officer | 1980 |
| Ms. Jennifer L. Yoss | VP of Accounting | 1978 |
| Mr. Maxim Shishin | Chief Information Officer | 1975 |
| Mr. Victor Gordon Clemons Sr. | Exec. Chairman | 1944 |
| Ms. Stefani P. Wendel | Investor Relation | NA |
| Sharon F. O'Connor | VP of Legal & HR | NA |
| Mr. Richard J. Schweppe | Sec. | 1955 |
| Mr. Victor Gordon Clemons Sr. | Executive Chairman | 1944 |
| Mr. Michael G. Combs | President & CEO | 1964 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.